ImmunoGenesis has a total of 56 patents globally, out of which 41 have been granted. Of these 56 patents, more than 83% patents are active. The United States is where ImmunoGenesis has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, the US seems to be the main focused R&D center of ImmunoGenesis and is also the origin country of the firm.
ImmunoGenesis was founded in the year 2019 by Michael Curran and William Tanner. The company specializes in science-driven immune therapies for tumor treatment.
Do read about some of the most popular patents of ImmunoGenesis which have been covered by us in this article and also you can find ImmunoGenesis patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over ImmunoGenesis patent portfolio.
How many patents does ImmunoGenesis have?
ImmunoGenesis has a total of 56 patents globally. These patents belong to 13 unique patent families. Out of 56 patents, 47 patents are active.
How Many Patents did ImmunoGenesis File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | ImmunoGenesis Applications Filed | ImmunoGenesis Patents Granted |
2022 | 1 | 5 |
2021 | 1 | 11 |
2020 | – | 3 |
2019 | 1 | – |
2018 | 3 | 2 |
2017 | 2 | 2 |
2016 | 8 | 1 |
2015 | 2 | 3 |
2014 | 1 | 3 |
2013 | 8 | 4 |
2012 | 3 | 3 |
2011 | 7 | 2 |
How many ImmunoGenesis patents are Alive/Dead?
Worldwide Patents
How Many Patents did ImmunoGenesis File in Different Countries?
Countries in which ImmunoGenesis Filed Patents
Country | Patents |
United States Of America | 19 |
Europe | 7 |
Japan | 6 |
Spain | 5 |
Australia | 5 |
Germany | 5 |
Canada | 3 |
Austria | 2 |
Hong Kong (S.A.R.) | 2 |
Italy | 1 |
Taiwan | 1 |
Where are Research Centres of ImmunoGenesis Patents Located?
10 Best ImmunoGenesis Patents
US8299088B2 is the most popular patent in the ImmunoGenesis portfolio. It has received 34 citations so far.
Below is the list of 10 most cited patents of ImmunoGenesis:
Publication Number | Citation Count |
US8299088B2 | 34 |
US20140010805A1 | 26 |
US7550496B2 | 14 |
US8003625B2 | 12 |
US8507464B2 | 9 |
US8946275B2 | 7 |
US20140171389A1 | 4 |
US8552048B2 | 2 |
JP5180824B2 | 2 |
US8664204B2 | 1 |
What are ImmunoGenesis’ key innovation segments?
What Technologies are Covered by ImmunoGenesis?
The chart below distributes patents filed by ImmunoGenesis